

TB-LAMP has satisfactory performance for detecting pulmonary tuberculosis in adolescents and adults and is a potential alternative to molecular tests that require more advanced infrastructure. However, the inability to detect rifampicin resistance is an important limitation of TB-LAMP. Future research should focus on well powered studies to establish the diagnostic accuracy of TB-LAMP for extrapulmonary tuberculosis sites.
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet